Use of statins linked to lower death rate in Covid patients: Study
June 25, 2020  12:17
image
Using cholesterol-lowering drugs called statins is associated with a lower death rate in patients hospitalised with COVID-19, according to a large-scale study. 


The research, published in the journal Cell Metabolism, also showed that mortality risk and other negative outcomes were not increased by combination therapy consisting of statins and blood pressure-lowering drugs called angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). 


"These results support the safety and potential benefits of statin therapy in hospitalised patients with COVID-19 and provide a rationale for prospective studies to determine whether statins confer protection against COVID-19-associated mortality," said study senior author Hongliang Li of Wuhan University in China. 


"Moreover, our findings represent an important contribution to the accumulating clinical evidence regarding the beneficial or detrimental effects of prescribing ACE inhibitors or ARBs to patients with COVID-19," Li said. 


Currently, there is no vaccine or specific antiviral drug approved to prevent or treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19, the researchers noted. Because a vaccine or drugs for COVID-19 will likely not be available for months or even years, repurposing clinically approved therapies might be a more attractive option, they said. -- PTI
« Back to LIVE

TOP STORIES